Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
CA: a Cancer Journal for Clinicians
|
September 1, 1986
Carcinoma of the penis
L Persky, J deKernion
The Journal of Urology
|
May 1, 1984
Subepithelial hematoma of the renal pelvis (Antopol-Goldman lesion): a case report and review of the literature
S Levitt, J Waisman, J deKernion
Seminars in Urology
|
February 1, 1992
Immunotherapy for renal cell carcinoma
A Belldegrun, R Figlin, J Danella, et al.
JAMA
|
August 5, 1974
Malignant melanoma metastatic to the bladder. Regression following intratumor injection of BCG vaccine
M J Silverstein, J DeKernion, D L Morton
Journal of Andrology
|
November 1, 1983
Human reproductive tissues contain thyrotropin releasing hormone (TRH) and TRH-homologous peptides
A E Pekary, R Ross, J deKernion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma
R A Figlin, A Belldegrun, N Moldawer, et al.
Cancer Treatment Reports
|
November 1, 1978
Preliminary report of the use of levamisole in the treatment of bladder cancer
R B Smith, J deKernion, B Lincoln, et al.
The Journal of Urology
|
March 1, 1978
Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report
R B Smith, J Dekernion, B Baron, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1993
Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy
A Belldegrun, W Pierce, D Sayah, et al.
The Cancer Journal From Scientific American
|
February 11, 1998
Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients
R Figlin, B Gitlitz, J Franklin, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
CA: a Cancer Journal for Clinicians
|
September 1, 1986
Carcinoma of the penis
L Persky, J deKernion
The Journal of Urology
|
May 1, 1984
Subepithelial hematoma of the renal pelvis (Antopol-Goldman lesion): a case report and review of the literature
S Levitt, J Waisman, J deKernion
Seminars in Urology
|
February 1, 1992
Immunotherapy for renal cell carcinoma
A Belldegrun, R Figlin, J Danella, et al.
JAMA
|
August 5, 1974
Malignant melanoma metastatic to the bladder. Regression following intratumor injection of BCG vaccine
M J Silverstein, J DeKernion, D L Morton
Journal of Andrology
|
November 1, 1983
Human reproductive tissues contain thyrotropin releasing hormone (TRH) and TRH-homologous peptides
A E Pekary, R Ross, J deKernion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma
R A Figlin, A Belldegrun, N Moldawer, et al.
Cancer Treatment Reports
|
November 1, 1978
Preliminary report of the use of levamisole in the treatment of bladder cancer
R B Smith, J deKernion, B Lincoln, et al.
The Journal of Urology
|
March 1, 1978
Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report
R B Smith, J Dekernion, B Baron, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
April 1, 1993
Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy
A Belldegrun, W Pierce, D Sayah, et al.
The Cancer Journal From Scientific American
|
February 11, 1998
Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients
R Figlin, B Gitlitz, J Franklin, et al.
Page
of 3